These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 35361635)
41. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women. Pearce K; Gleeson K; Tremellen K Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912 [TBL] [Abstract][Full Text] [Related]
42. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069 [TBL] [Abstract][Full Text] [Related]
43. Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis. Busnelli A; Somigliana E; Cirillo F; Levi-Setti PE Hum Reprod Update; 2021 Oct; 27(6):973-988. PubMed ID: 34254138 [TBL] [Abstract][Full Text] [Related]
44. Effects of postpartum diseases on antral follicle count and serum concentration of Anti-Müllerian hormone in dairy cows. Schwarzmann L; Marchand A; Knutti B; Bruckmaier R; Bollwein H; Scarlet D Anim Reprod Sci; 2023 Aug; 255():107291. PubMed ID: 37392501 [TBL] [Abstract][Full Text] [Related]
46. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Uncu G; Kasapoglu I; Ozerkan K; Seyhan A; Oral Yilmaztepe A; Ata B Hum Reprod; 2013 Aug; 28(8):2140-5. PubMed ID: 23624580 [TBL] [Abstract][Full Text] [Related]
47. The physiology and clinical utility of anti-Mullerian hormone in women. Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863 [TBL] [Abstract][Full Text] [Related]
48. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages. Grande M; Borobio V; Bennasar M; Stergiotou I; Mercadé I; Masoller N; Peñarrubia J; Borrell A Fertil Steril; 2015 May; 103(5):1221-7.e2. PubMed ID: 25796318 [TBL] [Abstract][Full Text] [Related]
49. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Baker VL; Gracia C; Glassner MJ; Schnell VL; Doody K; Coddington CC; Shin SS; Marshall LA; Alper MM; Morales AJ; Pavone ME; Behera MA; Zbella EA; Shapiro BS; Straseski JA; Broyles DL Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708 [TBL] [Abstract][Full Text] [Related]
50. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH? Landersoe SK; Larsen EC; Forman JL; Birch Petersen K; Kroman MS; Frederiksen H; Juul A; Nøhr B; Løssl K; Nielsen HS; Nyboe Andersen A Gynecol Endocrinol; 2020 Dec; 36(12):1090-1095. PubMed ID: 32362164 [TBL] [Abstract][Full Text] [Related]
52. Subclinical Hypothyroidism Is Associated with Lower Ovarian Reserve in Women Aged 35 Years or Older. Rao M; Wang H; Zhao S; Liu J; Wen Y; Wu Z; Yang Z; Su C; Su Z; Wang K; Tang L Thyroid; 2020 Jan; 30(1):95-105. PubMed ID: 31650898 [No Abstract] [Full Text] [Related]
53. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL; Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350 [TBL] [Abstract][Full Text] [Related]
54. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Iliodromiti S; Anderson RA; Nelson SM Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055 [TBL] [Abstract][Full Text] [Related]
55. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964 [TBL] [Abstract][Full Text] [Related]
56. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial. Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720 [TBL] [Abstract][Full Text] [Related]
57. Effects of vitamin D supplementation on ovarian reserve markers in infertile women with diminished ovarian reserve. Bacanakgil BH; İlhan G; Ohanoğlu K Medicine (Baltimore); 2022 Feb; 101(6):e28796. PubMed ID: 35147111 [TBL] [Abstract][Full Text] [Related]
58. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene. Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686 [TBL] [Abstract][Full Text] [Related]